Results 161 to 170 of about 48,625 (267)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation

, 2006
This study was performed to assess and compare the effects of raloxifene and alendronate for the treatment of postmenopausal osteoporosis. Thirty-two women with postmenopausal osteoporosis (raloxifene group:16 patients, alendronate group: 16 patients ...
Ayhan Erkek, Cavidan Ay, Ömer Faruk Şendur, Bengü Beydağ Odabaşı, Gülcan Gürer   +4 more
core  

A Cross-Tissue Multiomics Analysis Reveals the Protective Role of TGFBR3 in Postmenopausal Osteoporosis. [PDF]

Int J Genomics
Liu Y, Xie C, Yang K, Liu Z, Liu R, Hou X, Xing L, Gao J, Lian Q, Hu Y, Wang Y, Zhang L, Tian F.   +12 more
europepmc   +1 more source

Enhancing Breast Cancer Survivorship Care: The Role of Nurses in Post‐Treatment Follow‐Up—A Scoping Review

Journal of Advanced Nursing, Volume 82, Issue 6, Page 5659-5674, June 2026.
ABSTRACT Aim To examine the role of nurses in providing post‐treatment follow‐up care to breast cancer survivors, and to assess the impact of this care on survivors' satisfaction. Methods Scoping review. Data Sources An electronic literature search from PubMed and CINAHL databases was conducted, covering the period from 2013 to November 2023.
Judith Gálvez‐Sánchez, Nelia Soto‐Ruiz, Paula Escalada‐Hernández, Ana Carolina Andrade Biaggi Leite, Cristina García‐Vivar   +4 more
wiley   +1 more source

Macrophage polarization regulates bone homeostasis: a potential etiology and therapy for postmenopausal osteoporosis. [PDF]

Front Immunol
Danzeng Q, Wu F, Cui M, Shen Y, Li Y, Jiao J, Jiang W.   +6 more
europepmc   +1 more source

The Effect of Vitamin D3 Supplementation on the Risk of Falls in a General Population—The Finnish Vitamin D Trial

Journal of the American Geriatrics Society, Volume 74, Issue 6, Page 1548-1557, June 2026.
ABSTRACT Background The impact of vitamin D on fall incidence remains controversial. We studied the effect of 5 years of vitamin D3 supplementation on the risk of falls in a double‐blind, placebo‐controlled randomized trial with generally healthy, community‐dwelling men and women in Finland.
Toni Rikkonen, Sari Hantunen, Heikki Kröger, Christel Lamberg‐Allardt, JoAnn E. Manson, Tarja Nurmi, Marjo Tuppurainen, Ari Voutilainen, Tomi‐Pekka Tuomainen, Jyrki K. Virtanen   +9 more
wiley   +1 more source

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review. [PDF]

Cureus
Mann RS, Chopra I, Kilic A, Saxena A, Khan B, Rupanshu R, Chavez Cavalie PS.   +6 more
europepmc   +1 more source

Osteoblast‐Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
Osteoblast‐derived matricellular protein osteomodulin (OMD) critically regulates bone remodeling homeostasis via directly and competitively binding to RANKL, the master cytokine driving osteoclast formation. OMD shares overlapping binding sites on RANKL with osteoprotegerin and functional receptor RANK.
Meiling Jing, Xiaohan Zhu, Yueyi Yang, Xuchen Hu, Wenduo Tan, Xiaoyu Liu, Yujie Zhang, Xin Wang, Chenguang Niu, Zhengwei Huang   +9 more
wiley   +1 more source

Alendronate improves QOL of postmenopausal women with osteoporosis

, 2010
Hisaya Kawate1, Keizo Ohnaka2, Masahiro Adachi1, Suminori Kono3, Hideyuki Ikematsu4, Hisashi Matsuo5, Kazumi Higuchi6, Takehiko Takayama7, Ryoichi Takayanagi11Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu ...
Keizo Ohnaka, Hisaya Kawate, et al, Masahiro Adachi   +3 more
core  

Postmenopausal osteoporosis and vascular calcification: The estrogen regulation network and calcification paradox. [PDF]

J Transl Int Med
Lin Y, Jiang P, Lv Y, Tian W.
europepmc   +1 more source

SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
This graphical abstract illustrates that SCD1 inhibition by A939572 or the targeted nanovesicle POCM‐NP@A939572 reprograms arachidonic acid metabolism via the COX1‐HPGDS‐PGD2 axis and impairs mitochondrial homeostasis, thereby suppressing osteoclastogenesis and alleviating bone loss in osteoporosis.
Yihao Zhao, Xiaoan Wei, Haihao Wu, Chengjun Yao, Zeyu Zheng, Weishao Chen, Zhenhua Feng, Bao Huang, Zimin Cai, Qize Xue, Jian Chen, Fengdong Zhao, Junhui Liu   +12 more
wiley   +1 more source